ZFP36 Regulates Vascular Smooth Muscle Contraction and Maintains Blood Pressure

Abstract Hypertension remains a major risk factor for cardiovascular diseases, but the underlying mechanisms are not well understood. Zinc finger protein 36 (ZFP36) is an RNA‐binding protein that regulates mRNA stability by binding to adenylate‐uridylate‐rich elements in the mRNA 3′‐untranslated reg...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiuru Cui, Yawei Wang, Hanlin Lu, Lei Wang, Xianwei Xie, Shenghao Zhang, Pavel Kovarik, Shuijie Li, Shanshan Liu, Qunye Zhang, Jianmin Yang, Cheng Zhang, Jinwei Tian, Yan Liu, Wencheng Zhang
Format: Article
Language:English
Published: Wiley 2025-01-01
Series:Advanced Science
Subjects:
Online Access:https://doi.org/10.1002/advs.202408811
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832593509719212032
author Xiuru Cui
Yawei Wang
Hanlin Lu
Lei Wang
Xianwei Xie
Shenghao Zhang
Pavel Kovarik
Shuijie Li
Shanshan Liu
Qunye Zhang
Jianmin Yang
Cheng Zhang
Jinwei Tian
Yan Liu
Wencheng Zhang
author_facet Xiuru Cui
Yawei Wang
Hanlin Lu
Lei Wang
Xianwei Xie
Shenghao Zhang
Pavel Kovarik
Shuijie Li
Shanshan Liu
Qunye Zhang
Jianmin Yang
Cheng Zhang
Jinwei Tian
Yan Liu
Wencheng Zhang
author_sort Xiuru Cui
collection DOAJ
description Abstract Hypertension remains a major risk factor for cardiovascular diseases, but the underlying mechanisms are not well understood. Zinc finger protein 36 (ZFP36) is an RNA‐binding protein that regulates mRNA stability by binding to adenylate‐uridylate‐rich elements in the mRNA 3′‐untranslated region. This study reveals that ZFP36 expression is highly elevated in the arteries of hypertensive patients and rodents. In cultured vascular smooth muscle cell (VSMC), angiotensin II (AngII) activates poly (ADP‐ribose) polymerases1 (PARP1) to stimulate Zfp36 expression at the transcriptional level. VSMC‐specific ZFP36 deletion reduces vessel contractility and blood pressure levels in mice. Mechanistically, ZFP36 regulates G protein‐coupled receptors (GPCRs)‐mediated increases in intracellular calcium levels through impairing the mRNA stability of regulator of G protein signaling 2 (RGS2). Moreover, the VSMC‐specific ZFP36 deficiency attenuates AngII‐induced hypertension and vascular remodeling in mice. AAV‐mediated ZFP36 knockdown ameliorates spontaneous hypertension in rats. These findings elucidate that ZFP36 plays an important role in the regulation of smooth muscle contraction and blood pressure through modulating RGS2 expression. ZFP36 inhibition may represent a new therapeutic strategy for the treatment of hypertension.
format Article
id doaj-art-f0544ce09cc140adbbe028e130e9edb6
institution Kabale University
issn 2198-3844
language English
publishDate 2025-01-01
publisher Wiley
record_format Article
series Advanced Science
spelling doaj-art-f0544ce09cc140adbbe028e130e9edb62025-01-20T13:04:18ZengWileyAdvanced Science2198-38442025-01-01123n/an/a10.1002/advs.202408811ZFP36 Regulates Vascular Smooth Muscle Contraction and Maintains Blood PressureXiuru Cui0Yawei Wang1Hanlin Lu2Lei Wang3Xianwei Xie4Shenghao Zhang5Pavel Kovarik6Shuijie Li7Shanshan Liu8Qunye Zhang9Jianmin Yang10Cheng Zhang11Jinwei Tian12Yan Liu13Wencheng Zhang14State Key Laboratory for Innovation and Transformation of Luobing Theory Key Laboratory of Cardiovascular Remodeling and Function Research Chinese Ministry of Education Chinese National Health Commission and Chinese Academy of Medical Sciences Department of Cardiology Qilu Hospital of Shandong University Jinan 250012 ChinaState Key Laboratory for Innovation and Transformation of Luobing Theory Key Laboratory of Cardiovascular Remodeling and Function Research Chinese Ministry of Education Chinese National Health Commission and Chinese Academy of Medical Sciences Department of Cardiology Qilu Hospital of Shandong University Jinan 250012 ChinaState Key Laboratory for Innovation and Transformation of Luobing Theory Key Laboratory of Cardiovascular Remodeling and Function Research Chinese Ministry of Education Chinese National Health Commission and Chinese Academy of Medical Sciences Department of Cardiology Qilu Hospital of Shandong University Jinan 250012 ChinaState Key Laboratory for Innovation and Transformation of Luobing Theory Key Laboratory of Cardiovascular Remodeling and Function Research Chinese Ministry of Education Chinese National Health Commission and Chinese Academy of Medical Sciences Department of Cardiology Qilu Hospital of Shandong University Jinan 250012 ChinaDepartment of Cardiology Second Affiliated Hospital of Harbin Medical University Heilongjiang Provincial Key Laboratory of Panvascular Disease The Key Laboratory of Myocardial Ischemia Ministry of Education Harbin 150086 ChinaDepartment of Cardiology Second Affiliated Hospital of Harbin Medical University Heilongjiang Provincial Key Laboratory of Panvascular Disease The Key Laboratory of Myocardial Ischemia Ministry of Education Harbin 150086 ChinaMax Perutz Labs University of Vienna Vienna Biocenter (VBC), Dr. Bohr‐Gasse 9 Vienna A‐1030 AustriaDepartment of Biopharmaceutical Sciences College of Pharmacy Harbin Medical University Harbin 150081 ChinaState Key Laboratory of Transvascular Implantation Devices Heart Regeneration and Repair Key Laboratory of Zhejiang Province Department of Cardiology The Second Affiliated Hospital School of Medicine Zhejiang University Hangzhou 310009 ChinaState Key Laboratory for Innovation and Transformation of Luobing Theory Key Laboratory of Cardiovascular Remodeling and Function Research Chinese Ministry of Education Chinese National Health Commission and Chinese Academy of Medical Sciences Department of Cardiology Qilu Hospital of Shandong University Jinan 250012 ChinaState Key Laboratory for Innovation and Transformation of Luobing Theory Key Laboratory of Cardiovascular Remodeling and Function Research Chinese Ministry of Education Chinese National Health Commission and Chinese Academy of Medical Sciences Department of Cardiology Qilu Hospital of Shandong University Jinan 250012 ChinaState Key Laboratory for Innovation and Transformation of Luobing Theory Key Laboratory of Cardiovascular Remodeling and Function Research Chinese Ministry of Education Chinese National Health Commission and Chinese Academy of Medical Sciences Department of Cardiology Qilu Hospital of Shandong University Jinan 250012 ChinaDepartment of Cardiology Second Affiliated Hospital of Harbin Medical University Heilongjiang Provincial Key Laboratory of Panvascular Disease The Key Laboratory of Myocardial Ischemia Ministry of Education Harbin 150086 ChinaState Key Laboratory for Innovation and Transformation of Luobing Theory Key Laboratory of Cardiovascular Remodeling and Function Research Chinese Ministry of Education Chinese National Health Commission and Chinese Academy of Medical Sciences Department of Cardiology Qilu Hospital of Shandong University Jinan 250012 ChinaState Key Laboratory for Innovation and Transformation of Luobing Theory Key Laboratory of Cardiovascular Remodeling and Function Research Chinese Ministry of Education Chinese National Health Commission and Chinese Academy of Medical Sciences Department of Cardiology Qilu Hospital of Shandong University Jinan 250012 ChinaAbstract Hypertension remains a major risk factor for cardiovascular diseases, but the underlying mechanisms are not well understood. Zinc finger protein 36 (ZFP36) is an RNA‐binding protein that regulates mRNA stability by binding to adenylate‐uridylate‐rich elements in the mRNA 3′‐untranslated region. This study reveals that ZFP36 expression is highly elevated in the arteries of hypertensive patients and rodents. In cultured vascular smooth muscle cell (VSMC), angiotensin II (AngII) activates poly (ADP‐ribose) polymerases1 (PARP1) to stimulate Zfp36 expression at the transcriptional level. VSMC‐specific ZFP36 deletion reduces vessel contractility and blood pressure levels in mice. Mechanistically, ZFP36 regulates G protein‐coupled receptors (GPCRs)‐mediated increases in intracellular calcium levels through impairing the mRNA stability of regulator of G protein signaling 2 (RGS2). Moreover, the VSMC‐specific ZFP36 deficiency attenuates AngII‐induced hypertension and vascular remodeling in mice. AAV‐mediated ZFP36 knockdown ameliorates spontaneous hypertension in rats. These findings elucidate that ZFP36 plays an important role in the regulation of smooth muscle contraction and blood pressure through modulating RGS2 expression. ZFP36 inhibition may represent a new therapeutic strategy for the treatment of hypertension.https://doi.org/10.1002/advs.202408811blood pressurehypertensionsmooth muscle contractionZFP36
spellingShingle Xiuru Cui
Yawei Wang
Hanlin Lu
Lei Wang
Xianwei Xie
Shenghao Zhang
Pavel Kovarik
Shuijie Li
Shanshan Liu
Qunye Zhang
Jianmin Yang
Cheng Zhang
Jinwei Tian
Yan Liu
Wencheng Zhang
ZFP36 Regulates Vascular Smooth Muscle Contraction and Maintains Blood Pressure
Advanced Science
blood pressure
hypertension
smooth muscle contraction
ZFP36
title ZFP36 Regulates Vascular Smooth Muscle Contraction and Maintains Blood Pressure
title_full ZFP36 Regulates Vascular Smooth Muscle Contraction and Maintains Blood Pressure
title_fullStr ZFP36 Regulates Vascular Smooth Muscle Contraction and Maintains Blood Pressure
title_full_unstemmed ZFP36 Regulates Vascular Smooth Muscle Contraction and Maintains Blood Pressure
title_short ZFP36 Regulates Vascular Smooth Muscle Contraction and Maintains Blood Pressure
title_sort zfp36 regulates vascular smooth muscle contraction and maintains blood pressure
topic blood pressure
hypertension
smooth muscle contraction
ZFP36
url https://doi.org/10.1002/advs.202408811
work_keys_str_mv AT xiurucui zfp36regulatesvascularsmoothmusclecontractionandmaintainsbloodpressure
AT yaweiwang zfp36regulatesvascularsmoothmusclecontractionandmaintainsbloodpressure
AT hanlinlu zfp36regulatesvascularsmoothmusclecontractionandmaintainsbloodpressure
AT leiwang zfp36regulatesvascularsmoothmusclecontractionandmaintainsbloodpressure
AT xianweixie zfp36regulatesvascularsmoothmusclecontractionandmaintainsbloodpressure
AT shenghaozhang zfp36regulatesvascularsmoothmusclecontractionandmaintainsbloodpressure
AT pavelkovarik zfp36regulatesvascularsmoothmusclecontractionandmaintainsbloodpressure
AT shuijieli zfp36regulatesvascularsmoothmusclecontractionandmaintainsbloodpressure
AT shanshanliu zfp36regulatesvascularsmoothmusclecontractionandmaintainsbloodpressure
AT qunyezhang zfp36regulatesvascularsmoothmusclecontractionandmaintainsbloodpressure
AT jianminyang zfp36regulatesvascularsmoothmusclecontractionandmaintainsbloodpressure
AT chengzhang zfp36regulatesvascularsmoothmusclecontractionandmaintainsbloodpressure
AT jinweitian zfp36regulatesvascularsmoothmusclecontractionandmaintainsbloodpressure
AT yanliu zfp36regulatesvascularsmoothmusclecontractionandmaintainsbloodpressure
AT wenchengzhang zfp36regulatesvascularsmoothmusclecontractionandmaintainsbloodpressure